Log in to save to my catalogue

Clinical performance of an antibody-free assay for plasma A[beta]42/A[beta]40 to detect early altera...

Clinical performance of an antibody-free assay for plasma A[beta]42/A[beta]40 to detect early altera...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A732398617

Clinical performance of an antibody-free assay for plasma A[beta]42/A[beta]40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline

Publication information

Publisher

BioMed Central Ltd

More information

Scope and Contents

Contents

Background Accessible and cost-effective diagnostic tools are urgently needed to accurately quantify blood biomarkers to support early diagnosis of Alzheimer's disease (AD). In this study, we investigated the ability of plasma amyloid-beta (A[beta])42/A[beta]40 ratio measured by an antibody-free mass-spectrometric (MS) method, ABtest-MS, to detect...

Alternative Titles

Full title

Clinical performance of an antibody-free assay for plasma A[beta]42/A[beta]40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracacademiconefile_A732398617

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A732398617

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-022-01143-z

How to access this item